For millions of people, hand pain is more than just a minor annoyance. It can make everyday tasks frustrating, painful, and exhausting.
Simple actions such as opening jars, buttoning clothes, writing, cooking, or even holding a cup can become difficult when the joints in the hands hurt constantly.
One of the most common causes of this type of pain is hand osteoarthritis, often called hand OA. This condition affects the small joints in the fingers and hands, leading to pain, stiffness, swelling, and reduced movement. Many people also notice weakness in their grip and trouble performing daily activities.
Hand osteoarthritis becomes more common with age. Researchers estimate that by the age of 85, around half of all women and about one quarter of all men will develop the condition. Women are especially likely to experience hand OA after menopause, suggesting that hormonal changes may play a role.
Unlike rheumatoid arthritis, which is an autoimmune disease, osteoarthritis has traditionally been viewed as a “wear and tear” condition caused by gradual damage to joints over time. However, scientists are increasingly learning that inflammation may also play an important role in osteoarthritis pain and progression.
Unfortunately, treatment options for hand OA have been limited for many years. Doctors often recommend painkillers, anti-inflammatory medications, hand exercises, splints, or lifestyle changes. While these treatments may help some people temporarily, many patients continue living with significant pain and stiffness.
Now, new research from Monash University and Alfred Health in Australia is giving fresh hope to people with painful hand osteoarthritis.
The researchers tested a medication called methotrexate and found that it significantly reduced pain and stiffness in people with hand OA. The findings were published in the prestigious medical journal The Lancet.
Methotrexate is not a new drug. Doctors have been prescribing it since the 1980s to treat rheumatoid arthritis and several other inflammatory conditions. The medicine works by calming overactive immune responses and reducing inflammation inside the body.
Because inflammation is now believed to contribute to hand osteoarthritis in some patients, researchers wanted to investigate whether methotrexate might also help people with hand OA.
In the study, participants with painful hand osteoarthritis were divided into two groups. One group took 20 milligrams of methotrexate once each week for six months. The other group took a placebo, a fake treatment with no active medication.
Neither the patients nor the researchers knew who was receiving the real drug during the study. This type of research design helps scientists produce more reliable and unbiased results.
The findings were encouraging. People who took methotrexate reported much larger improvements in pain and stiffness compared with those taking the placebo.
According to the researchers, pain improvement in the methotrexate group was about twice as strong as the improvement seen in the placebo group. Even more importantly, patients continued improving gradually over time instead of reaching a quick plateau.
The study suggests that inflammation may play a bigger role in hand osteoarthritis than scientists once thought. If inflammation is contributing to pain and joint damage, medications that reduce inflammation could become important new treatment options.
Professor Flavia Cicuttini, the lead researcher, said the findings could eventually provide a major breakthrough for people living with hand OA, especially women affected around menopause.
The research team plans to continue studying methotrexate to better understand how long its benefits last and whether it might also help slow or prevent joint damage over time.
Researchers also want to identify which patients are most likely to benefit from the drug. Not all people with hand osteoarthritis have the same disease pattern, and some may respond better than others.
The study is important because methotrexate is already widely used by doctors and has been studied for decades. Its safety profile is well understood when monitored properly by healthcare professionals.
However, experts caution that methotrexate is still a powerful medication and should only be used under medical supervision. The drug can have side effects and usually requires regular blood tests to monitor liver function and overall health.
Still, the findings provide new hope for patients who have long struggled with limited treatment options.
Hand osteoarthritis may not receive as much public attention as other diseases, but it can strongly affect quality of life. Persistent pain and reduced hand function can limit independence, work ability, hobbies, and daily comfort.
As populations age, the number of people living with hand OA is expected to continue rising. Researchers say finding more effective treatments is becoming increasingly important.
The new study appears promising because it was carefully designed and published in a major medical journal. However, more research will still be needed before methotrexate becomes a standard treatment for hand osteoarthritis.
Future studies will help determine the best dosage, long-term safety, and whether the medication can slow joint damage in addition to reducing pain.
Even so, the findings represent an important step forward. For many people living with painful hands, the research offers something that has been missing for a long time: real hope for better relief and improved daily life.
If you care about bone health, please read studies that plant-based diets can harm your bone health without these nutrients, and how to ease arthritis with anti-inflammatory foods.
For more health information, please see recent studies that too much of this vitamin may increase your risk of bone fractures, and results showing this type of exercise may protect your bone health, slow down bone aging.
Copyright © 2026 Knowridge Science Report. All rights reserved.
